Chronic Pain Induces Anxiety with Concomitant Changes in Opioidergic Function in the Amygdala
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Clinically, it has been reported that chronic pain induces depression, anxiety, and reduced quality of life. The endogenous opioid system has been implicated in nociception, anxiety, and stress. The present study was undertaken to investigate whether chronic pain could induce anxiogenic effects and changes in the opioidergic function in the amygdala in mice. We found that either injection of complete Freund's adjuvant (CFA) or neuropathic pain induced by sciatic nerve ligation produced a significant anxiogenic effect at 4 weeks after the injection or surgery. Under these conditions, the selective mu-opioid receptor agonist [D-Ala2,N-MePhe4,Gly5-ol]-enkephalin (DAMGO)- and the selective delta-opioid receptor agonist (+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide (SNC80)-stimulated [35S]GTPgammaS binding in membranes of the amygdala was significantly suppressed by CFA injection or nerve ligation. CFA injection was associated with a significant increase in the kappa-opioid receptor agonist 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide hydrochloride (ICI199,441)-stimulated [35S]GTPgammaS binding in membranes of the amygdala. The intracerebroventricular administration and microinjection of a selective mu-opioid receptor antagonist, a selective delta-opioid receptor antagonist, and the endogenous kappa-opioid receptor ligand dynorphin A caused a significant anxiogenic effect in mice. We a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increases in the GTPgs binding of k-opioid receptor-specific ligands in the amygdala were associated with anxiety that was produced by Complete Freund's Adjuvantinduced chronic pain or sciatic nerve ligation-induced neuropathic pain (Narita et al., 2006).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Narita et al., 2006
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963 · cited 1×
“A guide cannula (AG-9, Eicom Co., Kyoto, Japan) was implanted into the basolateral amygdala (from bregma: posterior 2.8 mm, lateral + 5.0 mm, ventral 7.9 mm) according to the atlas of Paxinos and Watson (1998).”
InfluentialThe rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
PHARMACOLOGICAL EFFECTS PRODUCED BY INTRACEREBRAL INJECTION OF DRUGS IN THE CONSCIOUS MOUSE
HALEY, T. J., & McCORMICK, W. G. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb01354.x · Cited by 1,526 · cited 2×
“Intracerebroventricular administration was performed as described previously (Haley and McCormick, 1957).”
MethodOpioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292 · cited 3×
“The distributions of m-, d-, and k-opioid receptor mRNAs overlap in many brain regions including the amygdala (Mansour et al, 1995).”
BackgroundInfluentialCloning of a Delta Opioid Receptor by Functional Expression
Evans, C. J., Keith, D. E., Morrison, H., Magendzo, K., & Edwards, R. H. (1992) · Science · doi:10.1126/science.1335167 · Cited by 1,233 · cited 2×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
BackgroundAnatomy of CNS opioid receptors
Mansour, A., Khachaturian, H., Lewis, M. E., Akil, H., & Watson, S. J. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90093-8 · Cited by 1,194
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010 · cited 1×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
BackgroundPsychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857 · cited 2×
“Furthermore, k agonists produce a dysphoria similar to that noted in depression and chronic stress (Pfeiffer et al, 1986).”
BackgroundRegional Mu Opioid Receptor Regulation of Sensory and Affective Dimensions of Pain
Zubieta, J.-K., Smith, Y. R., Bueller, J. A., Xu, Y., Kilbourn, M. R., Jewett, D. M., Meyer, C. R., Koeppe, R. A., & Stohler, C. S. (2001) · Science · doi:10.1126/science.1060952 · Cited by 841 · cited 2×
“As previously reported in healthy human subjects, sustained pain induces a reduction of m-opioid receptor availability in the amygdala as measured by positron emission tomography (Zubieta et al, 2001).”
MethodMolecular cloning and functional expression of a mu opioid receptor from rat brain
Chen, Y., Mestek, A., Liu, J., Hurley, A., & Yu, L. (1994) · Regulatory Peptides · doi:10.1016/0167-0115(94)90214-3 · Cited by 810 · cited 1×
“Three opioid receptor types, m-, d-, and k-opioid receptors, have been successfully cloned (Evans et al, 1992; Kieffer et al, 1992; Chen et al, 1993; Fukuda et al, 1993; Meng et al, 1993; Wang et al, 1993; Yasuda et al, 1993).”
Background
Cited by
Items 101–200 of 289
Reversal of Monoarthritis-induced Affective Disorders by Diclofenac in Rats
Borges, G., Neto, F. L. M., Micó, J. A., & Berrocoso, E. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000177 · Cited by 51
Chronic pain causes a persistent anxiety state leading to increased ethanol intake in CD1 mice
González-Sepúlveda, M., Pozo, O. J., Marcos, J., & Valverde, O. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881115622238 · Cited by 40
“…CD1 mice with neuropathic pain rapidly develop anxiety-like responses (starting at PSD 5) and despair behaviour (starting at PSD 20) (Figure 4 and Figure 7(a)), earlier than that observed in C57BL/6J mice (Chen et al., 2013; Hasnie et al., 2007; Narita et al., 2006a, 2006b; Yalcin et al., 2011).”
ResultBurek, D., Massaly, N., Yoon, H. J., Doering, M. M., & Morón, J. A. (2021) · Pain · doi:10.1097/j.pain.0000000000002467 · Cited by 44
The role of delta opioid receptors in the anxiolytic actions of benzodiazepines
Primeaux, S. D., WILSON, S., MCDONALD, A., Mascagni, F., & Wilson, M. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.09.025 · Cited by 42
“Recent studies by Narita et al. (2006a) suggest that DOR receptor activity modulates levels of astrocytes in cingulate cortex, and that such alterations can modify anxiety levels in the elevated plus maze and light: dark transition tests (Narita et al. 2006b).”
BackgroundInfluentialThe role of experimental models in developing new treatments for irritable bowel syndrome
Holschneider, D. P., Bradesi, S., & Mayer, E. A. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.88 · Cited by 40
Paretkar, T., & Dimitrov, E. L. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.12.005 · Cited by 42
“On the other hand, long lasting pain reduces the activity of the μ- and δ-opioid receptors in the CeA, to which the enkephalin is a natural ligand, therefore reducing the inhibitory Enk transmission in the CeA (Narita et al., 2006).”
BackgroundBessière, B., Richebé, P., Laboureyras, E., Laulin, J., Contarino, A., & Simonnet, G. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.08.003 · Cited by 44
Hestehave, S., Abelson, K., Pedersen, T. B., Finn, D. P., Andersson, D. R., & Munro, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-77640-8 · Cited by 43
Huge, V., Rammes, G., Beyer, A., Zieglgänsberger, W., & Azad, S. C. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2008.03.010 · Cited by 42
“Recent animal data for instance suggest changes in opioidergic function including kappa opioid receptor activity in the amygdala in states of chronic pain (Narita et al., 2006).”
BackgroundNishinaka, T., Nakamoto, K., & Tokuyama, S. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.11.012 · Cited by 41
Pain-related cortico-limbic plasticity and opioid signaling
Neugebauer, V., Presto, P., Yakhnitsa, V., Antenucci, N., Mendoza, B., & Ji, G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109510 · Cited by 46
Chronic pain impact on rodents’ behavioral repertoire
Cunha, A. M., Pereira-Mendes, J., Almeida, A., Guimarães, M. R., & Leite‐Almeida, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.022 · Cited by 39
Refsgaard, L. K., Hoffmann-Petersen, J., Sahlholt, M., Pickering, D. S., & Andreasen, J. T. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.01.019 · Cited by 42
ERK1/2: Function, signaling and implication in pain and pain-related anxio-depressive disorders
Borges, G., Berrocoso, E., Micó, J. A., & Neto, F. L. M. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.010 · Cited by 41
Jassar, H., Nascimento, T. D., Kaciroti, N., DosSantos, M. F. H., Danciu, T., Koeppe, R. A., Smith, Y. R., BIGAL, M. E., Porreca, F., Casey, K. L., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101905 · Cited by 43
“In fact, in rodent models with noxious stimuli, opioidergic dysfunction in the amygdala has been strongly connected to an increase in anxiety-like behaviors (Narita et al., 2006a,b), especially when there is persistence of the pain inputs.”
BackgroundLimoges, A., Yarur, H. E., & Tejeda, H. A. (2022) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2022.963691 · Cited by 37
“Administration of complete Freund’s adjuvant (CFA) in mice increases G-protein stimulation in the CeA with the KOR agonist ICI 199,441 relative to saline-injected control mice (Narita et al., 2006), and Dyn content in the CeA of a functional pain model (Nation et al.”
MethodNishinaka, T., Kinoshita, M., Nakamoto, K., & Tokuyama, S. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.02.053 · Cited by 36
Murasawa, H., Kobayashi, H., Saeki, K., & Kitano, Y. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05356-3 · Cited by 34
Zhou, C., Wu, Y., Ding, X., Shi, N., Cai, Y., & Pan, Z. Z. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1259-19.2020 · Cited by 40
“Recently, a growing number of preclinical studies have demonstrated that chronic sensory pain can induce anxietyand depression-like behaviors in rodents (Narita et al., 2006; Caspani et al., 2014; Barthas et al., 2015; Wang et al., 2015, 2017; Gambeta et al., 2018).”
BackgroundLi, C.-Q., Zhang, J.-W., Dai, R., Wang, J., Luo, X., & Zhou, X. (2010) · Pain Research and Treatment · doi:10.1155/2010/705874 · Cited by 35
“These data showed that the anxiety-like behavior also developed in incisional pain model, as seen in chronic inflammatory pain [5] or neuropathic pain [19].”
BackgroundAnxiolytic-like effects of α-asarone in a mouse model of chronic pain
Tian, J., Tian, Z., Qin, S.-L., Zhao, P.-Y., Jiang, X., & Tian, Z. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0108-z · Cited by 35
Custodio-Patsey, L., Donahue, R. R., Fu, W., Lambert, J., Smith, B. N., & Taylor, B. K. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107726 · Cited by 38
Ko, M. J., Chiang, T., Mukadam, A. A., Mulia, G. E., Gutridge, A. M., Lin, A., Chester, J. A., & van Rijn, R. M. (2021) · Science Signaling · doi:10.1126/scisignal.aba0245 · Cited by 36
“In this manner, TAN67 acts as a functional antagonist, matching the anxiogenic effects of the OR antagonist naltrindole (61).”
BackgroundWu, Y., Jiang, Y., Shao, X., He, X., Shen, Z., Shi, Y., Wang, C., & Fang, J. (2019) · Journal of Pain Research · doi:10.2147/jpr.s211826 · Cited by 33
κ-Opioid receptor antagonism reverses heroin withdrawal-induced hyperalgesia in male and female rats
Marchette, R. C. N., Gregory‐Flores, A., Tunstall, B. J., Carlson, E. R., Jackson, S. N., Sulima, A., Rice, K. C., Koob, G. F., & Vendruscolo, L. F. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100325 · Cited by 35
Jiang, Y., Zhang, Y., Cui, S., Liu, F., Yi, M., & Wan, Y. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.01.041 · Cited by 31
Gambeta, E., Batista, M. A., Maschio, G. P., Turnes, J. D. M., Araya, E. I., & Chichorro, J. G. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.04.025 · Cited by 30
Sanganahalli, B. G., Chitturi, J., Hermán, P., Elkabes, S., Heary, R. F., Hyder, F., & Kannurpatti, S. S. (2021) · Journal of Neurotrauma · doi:10.1089/neu.2021.0190 · Cited by 31
“34 Although such brain parenchymal changes have been hypothesized as potential factors originating brain functional changes seen in individuals with chronic pain, the FCD results indicate that most nociceptive regions turned into active hubs for spontaneous neural activity in the resting brain…”
The atypical antidepressant mianserin exhibits agonist activity at κ‐opioid receptors
Olianas, M. C., Dedoni, S., & Onali, P. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02078.x · Cited by 32
“, 1986) and pro-depressivelike and anxiogenic effects in rodents (Bals-Kubik et al., 1993; Narita et al., 2006).”
BackgroundLi, Y., Zhang, K., Sun, T., Wang, J., Guo, Y., Yang, L., Yang, Q., Li, Y., Liu, S., Zhao, M., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1507-3 · Cited by 27
Huang, H., Liao, H.-Y., & Lin, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/4951591 · Cited by 34
“Louis, MO)) as previous study [29] in the plantar surface of the hind paw.”
ResultRGS9-2 modulates sensory and mood related symptoms of neuropathic pain
Terzi, D., Gaspari, S., Manouras, L., Descalzi, G., Mitsi, V., & Zachariou, V. (2014) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2014.08.005 · Cited by 29
“In preclinical models, several studies have demonstrated the development of anxiety- and depression-like behaviors in mice within a few weeks after nerve injury (Narita et al., 2006; Yalcin et al., 2011).”
Grégoire, S., Wattiez, A., Etienne, M., Marchand, F., & Ardid, D. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.03.056 · Cited by 31
Hoot, M. R., Sim‐Selley, L. J., Selley, D. E., Scoggins, K. L., & Dewey, W. L. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.023 · Cited by 28
“…sciatic nerve ligation in the mouse decreased μ-opioid stimulated [35S]GTPγS binding in the amygdala and ventral midbrain (including the ventral tegmental area), that was associatedwith anxiety and reduced morphine-mediated place preference, respectively (Narita et al., 2006; Ozaki et al., 2003).”
The effect of opiodergic system and testosterone on anxiety behavior in gonadectomized rats
Khakpai, F. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.013 · Cited by 29
Roca‐Lapirot, O., Fossat, P., Ma, S., Egron, K., Trigilio, G., López‐González, M. J., Covita, J., Bouali‐Benazzouz, R., Favereaux, A., Gundlach, A. L., et al. (2018) · Pain · doi:10.1097/j.pain.0000000000001408 · Cited by 27
Neurobiological aspects of pain in the context of alcohol use disorder
Cucinello‐Ragland, J. A., & Edwards, S. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.001 · Cited by 33
“While clinical reports of comorbid chronic pain and anxiety are highly variable across populations, chronic pain induced anxiety-like behavior is readily observed in both neuropathic and non-neuropathic animal models of pain (Bahaaddini, Khatamsaz, Esmaeili-Mahani, Abbasnejad, & Raoof, 2016; Dimitrov, Tsuda, Cameron,…”
BackgroundAcupuncture for Psychological Disorders Caused by Chronic Pain: A Review and Future Directions
Lin, L., Li, H., Yang, J., Hao, X.-W., Yan, S., Wang, Y., Yu, F.-T., Shi, G., & Liu, C. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.626497 · Cited by 29
“A study found that the prevalence of depression/anxiety was 27 and 14% between women and men; for pain, 24 and 19%, respectively (Narusyte et al., 2020).”
BackgroundSpinieli, R. L., Cazuza, R. A., Sales, A. J., Carolino, R. O. G., Martinez, D., Anselmo‐Franci, J. A., Tajerian, M., & Leite‐Panissi, C. R. A. (2022) · Molecular Pain · doi:10.1177/17448069221121307 · Cited by 30
Wang, Y., Hang, A., Lu, Y., Long, Y., Zan, G., Li, X., Wang, Q., Zhao, Z., He, L., Chi, Z., et al. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.022 · Cited by 30
Cao, H., Zheng, J., Li, J., Meng, B., Li, J., & Ge, R.-S. (2014) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-013-1549-9 · Cited by 26
Stress Influences Brain Enkephalinase, Oxytocinase and Angiotensinase Activities: A New Hypothesis
Hernández, J., Segarra, A. B., Ramírez, M. R., Banegas, I., de Gasparo, M., Alba, F., Vives, F., Durán, R., & Prieto, I. (2009) · Neuropsychobiology · doi:10.1159/000219306 · Cited by 30
“It has been observed that enkephalins are released in the central nervous system, particularly in the amygdala, in response to stress [”
BackgroundPain and anxiety and their relationship with medication doses in the intensive care unit
Park, S. Y., Na, S. H., Oh, J., Lee, J. S., Oh, S.-T., Kim, J., & Park, J. Y. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.05.014 · Cited by 26
Fisher, A. S., Lanigan, M. T., Upton, N., & Lione, L. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.614990 · Cited by 32
“Anxiety/depression like behaviors have recently shown utility within the preclinical setting and the study of neuropathic pain (Narita et al., 2006; Yalcin et al., 2011, Yalcin et al., 2014; AlbaDelgado et al., 2013).”
BackgroundAlmatroudi, A., Ostovar, M., Bailey, C. P., Husbands, S. M., & Bailey, S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14060 · Cited by 24
“This is perhaps surprising given that dynorphin has been shown to induce significant anxiogenic-like effects in mice in the EPM (Narita et al., 2005), while high affinity selective κ antagonists, norBNI and JDTic, have been shown to produce anxiolytic like effects (Knoll et al., 2007).”
BackgroundCoral-Pérez, S., Martínez-Martel, I., Martinez-Serrat, M., Batallé, G., Bai, X., Leite‐Panissi, C. R. A., & Pol, O. (2022) · Antioxidants · doi:10.3390/antiox11112153 · Cited by 28
“In mice with chronic inflammatory pain provoked by CFA, our aims are to evaluate: (1) the antinociceptive effects of the intraperitoneal and/or subplantar administration of hydrogen-rich water (HRW), (2) the feasible antidepressant and/or anxiolytic effects of HRW during chronic inflammatory pain, (3) the main pathway…”
BackgroundSolati, J. (2011) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2011.06.011 · Cited by 24
“The study by Sher in 2001 [37] showed that intracerebroventricular microinjections of d-opioid receptor antagonist cause a significant anxiogenic effect in mice [40].”
BackgroundTemporal Dynamics of Anxiety Phenotypes in a Dental Pulp Injury Model
Shang, L., Xu, T., Li, F. Y., Su, J., & Li, W. (2015) · Molecular Pain · doi:10.1186/s12990-015-0040-3 · Cited by 27
Long‐term effects of neonatal handling on mu‐opioid receptor levels in the brain of the offspring
Kiosterakis, G., Stamatakis, A., Diamantopoulou, A., Fameli, M., & Stylianopoulou, F. (2009) · Developmental Psychobiology · doi:10.1002/dev.20383 · Cited by 27
Massaly, N., Temp, J., Machelska, H., & Stein, C. (2020) · Pain · doi:10.1097/j.pain.0000000000001968 · Cited by 21
Zhou, W., Li, Y., Meng, X., Liu, A., Mao, Y., Zhu, X., Meng, Q., Jin, Y., Zhang, Z., & Tao, W. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100277 · Cited by 24
“Discussion Pain and anxiety are frequently encountered together in the clinic (23, 36).”
BackgroundResultInfluentialA nigra–subthalamic circuit is involved in acute and chronic pain states
Cui, Y., Jia, T., Luan, Y., Zhang, X., Xiao, C., & Zhou, C. (2022) · Pain · doi:10.1097/j.pain.0000000000002588 · Cited by 24
Borges, G., Miguélez, C., Neto, F. L. M., Micó, J. A., Ugedo, L., & Berrocoso, E. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx005 · Cited by 22
“We previously reported that prolonged experimental arthritis produces anxiety-like behavior in rats (Borges et al., 2014), as also observed elsewhere (Narita et al., 2006; Amorim et al., 2014).”
BackgroundPain vulnerability and DNA methyltransferase 3a involved in the affective dimension of chronic pain
Wang, W., Li, C., Cai, Y., & Pan, Z. Z. (2017) · Molecular Pain · doi:10.1177/1744806917726713 · Cited by 23
Margolis, E. B., Moulton, M. G., Lambeth, P. S., & O’Meara, M. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109376 · Cited by 24
Bétourné, A., Familiades, J., Lacassagne, L., Halley, H., Cazalès, M., Ducommun, B., Lassalle, J. M., Zajac, J., & Francès, B. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.045 · Cited by 24
“found a desensitization of mu and delta receptors during neuropathic and CFA inflammatory pain while kappa receptors where upregulated only after CFA injection (Narita et al., 2006).”
Johnston, I. N., Maier, S. F., Rudy, J. W., & Watkins, L. R. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.048 · Cited by 22
Analgesic Drugs Combinations in the Treatment of Different Types of Pain
Ortiz, M. I., Molina, M. A. R., Arai, Y.-C. P., & Romanò, C. L. (2012) · Pain Research and Treatment · doi:10.1155/2012/612519 · Cited by 26
Lorente, J. D., Cuitavi, J., Campos‐Jurado, Y., Montón-Molina, R., González-Romero, J. L., & Hipólito, L. (2021) · Pain · doi:10.1097/j.pain.0000000000002332 · Cited by 23
Anxiolytic effects of sesamin in mice with chronic inflammatory pain
Guo, H.-L., Xiao, Y., Tian, Z., Li, X., Wang, D., Wang, X., Zhang, Z.-W., Zhao, M., & Liu, S. (2015) · Nutritional Neuroscience · doi:10.1179/1476830515y.0000000015 · Cited by 22
Llorca-Torralba, M., Pilar-Cuéllar, F., Borges, G., Micó, J. A., & Berrocoso, E. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109857 · Cited by 21
Gonçalves, L., Friend, L., & Dickenson, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.032 · Cited by 18
“μ-opioid agonist binding in the amygdala and ventral midbrain decreases after chronic nerve injury (Martin et al., 2011; Narita et al., 2006), changes thought to contribute to the establishment and maintenance of chronic pain.”
Nozaki, C., & Kamei, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.029 · Cited by 18
Hayashi, T., Miyata, M., Nagata, T., Izawa, Y., & Kawakami, Y. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.029 · Cited by 18
“Moreover, anticipatory anxiety induced by pain involves the PFC (Simpson et al., 2001) and the amygdala (Narita et al., 2006), suggesting that these brain areas may be key to elucidating the connection between pain and depression.”
BackgroundEffects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice.
Neelakantan, H., Ward, S. J., & Walker, E. A. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000097 · Cited by 17
“…(Narita et al., 2004; Niikura, Narita, Butelman, Kreek, & Suzuki, 2010; Ozaki, Narita, Iino, Miyoshi, & Suzuki, 2003; Ozaki et al., 2002), nucleus accumbens (Altier & Stewart, 1999; Baliki et al., 2013), and amygdala (Goncalves et al., 2008; Narita et al., 2006; Neugebauer, Li, Bird, & Han, 2004).”
Burek, D., Massaly, N., Doering, M. M., Zec, A., Gaelen, J. I., & Morón, J. A. (2021) · Pain · doi:10.1097/j.pain.0000000000002179 · Cited by 18
Chapman, C., Woo, N. T., & Maluf, K. S. (2022) · Physical Therapy · doi:10.1093/ptj/pzac081 · Cited by 33
“4,7,8 Pain impacts the general population to the extent that international law recognizes pain management as a basic human right.”
Guo, H., Hu, W., Xian, H., Shi, Y., Liu, Y., Ma, S., Pan, K.-Q., Wu, S., Xu, L., Luo, C., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03881-z · Cited by 17
“Chronic pain creates unpleasant emotional states and induces negative emotions such as anxiety and depressive disorders, while anxiety enhances the perception of pain [13, 14].”
Evaluation of anxiety-like behaviour in a rat model of acute postoperative pain
Kouya, F., Iqbal, Z., Charen, D. A., Shah, M., & Banik, R. K. (2014) · European Journal of Anaesthesiology · doi:10.1097/eja.0000000000000052 · Cited by 16
Caputi, F. F., Rullo, L., Stamatakos, S., Candeletti, S., & Romualdi, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164010 · Cited by 19
“However, other authors suggest a therapeutic potential for κ agonists when their antinociceptive effect is mediated by the absence of arrestin recruitment [48], although KOR supraspinal activation drives anxiety and dysphoria, as has been previously demonstrated [49].”
BackgroundZareie, F., Ghalebandi, S., Askari, K., Mousavi, Z., & Haghparast, A. (2021) · Peptides · doi:10.1016/j.peptides.2021.170679 · Cited by 17
A Bio-Psycho-Socio-Molecular Approach to Pain and Stress Management
Esch, T., & Stefano, G. B. (2007) · Complementary Medicine Research · doi:10.1159/000105671 · Cited by 20
Neumann, E., Küpfer, L., & Zeilhofer, H. U. (2020) · Pain · doi:10.1097/j.pain.0000000000002030 · Cited by 15
“especially since a2GABAARmodulators, including TPA023B, are anxiolytic(18,28) and because animals with neuropathic pain exhibit elevated levels of anxiety.(22,26) To exclude false-positive effects”
BackgroundSlivicki, R. A., Yi, J., Brings, V. E., Huynh, P. N., & Gereau, R. W. (2021) · Pain · doi:10.1097/j.pain.0000000000002550 · Cited by 16
Mendes-Gomes, J., Paschoalin-Maurin, T., Donaldson, L. F., Lumb, B. M., Blanchard, D. C., & Coimbra, N. C. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146907 · Cited by 19
Herpes zoster in patients with sciatica
Ke, D.-S., Hsu, C.-Y., Lin, C., Hsu, C. Y., & Kao, C. (2020) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-020-03847-5 · Cited by 18
“The patients with chronic pain may experience depression [17].”
BackgroundRaghav, R., Jain, R., Jacob, T. G., Dhawan, A., & Roy, T. S. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05765-3 · Cited by 14
Ducret, E., Jacquot, F., Descheemaeker, A., Dallel, R., & Artola, A. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.03.012 · Cited by 15
Palmisano, M., Mercatelli, D., Caputi, F. F., Carretta, D., Romualdi, P., & Candeletti, S. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12365 · Cited by 16
“In fact, chronic neuropathic pain induces reorganization and functional changes (Narita et al. 2006) in cortical and subcortical structures (Apkarian et al.”
BackgroundZhao, H., Xue, Q., Li, C., Wang, Q., Han, S., Zhou, Y., Yang, T., Xie, Y., Fu, H., Lu, C., et al. (2020) · Molecular Brain · doi:10.1186/s13041-020-0555-z · Cited by 15
Wei, N., Guo, Z., Ye, R., Guan, L., Ren, J., Liang, Y., Shao, X., Fang, J., Fang, J., & Du, J. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.02.015 · Cited by 21
“Among the 66 experimental studies included in the literature review (Urban et al., 2011; Zheng et al., 2017; Narita et al., 2006; Parent et al., 2012; Baiamonte et al., 2013; Maciel et al., 2013; Lee et al., 2014; Lima et al., 2014; Wang et al., 2015a, 2015b; Su et al., 2015; da SA et al., 2016;…”
Involvement of Neuroactive Steroids in Pain, Depression and Anxiety
Mifflin, K. A., Benson, C. A., Kerr, B. J., Arıcıoğlu, F., Çetin, M., Dursun, S. M., & Baker, G. B. (2015) · Modern trends in psychiatry · doi:10.1159/000435935 · Cited by 14
Effects of Combined Opioids on Pain and Mood in Mammals
Rech, R. H., Mokler, D. J., & Briggs, S. L. (2012) · Pain Research and Treatment · doi:10.1155/2012/145965 · Cited by 16
“[96, 97]).”
Wang, X., Jiang, Y., Lu, L., Feng, B., Ma, X., Zhang, K., Guan, S., Yang, L., Fan, Q., Zhu, X.-C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.887238 · Cited by 15
“persists fromweeks tomonths, so its pathophysiological featuresare suitable for studying chronic inflammatory pain and pain-related psychiatric comorbidities (45).”
BackgroundFerdousi, M. I., Calcagno, P., Sánchez, C., Smith, K. L., Kelly, J. P., Roche, M., & Finn, D. P. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2023.1131069 · Cited by 21
Lorente, J. D., Cuitavi, J., Campos‐Jurado, Y., & Hipólito, L. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24703 · Cited by 14
Salamon, E., Esch, T., & Stefano, G. B. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.18.3.465 · Cited by 18
“respectively (22,27,46-51) .”
Advances in the Treatment of Neuropathic Pain by Sympathetic Regulation
Xu, P., Fan, H. R., Zhang, E. M., Zhang, H. N., & Fei, Y. (2024) · Current Pain and Headache Reports · doi:10.1007/s11916-024-01285-9 · Cited by 12
Baastrup, C., Jensen, T. S., & Finnerup, N. B. (2011) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2011.02.001 · Cited by 14
Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction
Cahill, C. M., Lueptow, L. M., Kim, H., Shusharla, R., Bishop, A., & Evans, C. J. (2021) · Handbook of experimental pharmacology · doi:10.1007/164_2021_434 · Cited by 15
Gambeta, E., Kopruszinski, C. M., dos Reis, R. C., Zanoveli, J. M., & Chichorro, J. G. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.035 · Cited by 14
“Regarding the animal species, it is noteworthy that a previous study has reported the development of anxiety-like behavior 4 weeks after induction of an inflammatory or neuropathic pain-state in mice, suggesting that these behaviors could be related (Narita et al., 2006).”
Niewöhner, J., Kehl, C., & Beck, S. (2008) · transcript Verlag eBooks · doi:10.14361/9783839409268 · Cited by 27
Saffarpour, S., & Nasirinezhad, F. (2020) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2020-0037 · Cited by 11
“Although the relationship between neuropathic pain and anxiety was perceived, the factors involved in this interaction are incompletely known yet [54, 61].”
BackgroundTull, M. T., Edmonds, K. A., Forbes, C. N., Richmond, J. R., Rose, J. P., Anestis, M. D., & Gratz, K. L. (2020) · Substance Use & Misuse · doi:10.1080/10826084.2020.1741632 · Cited by 13
“, 2011), and the experience of pain may contribute to negative affect (Narita et al., 2006; LeBlanc et al., 2015).”
BackgroundThe Dynorphin/-Opioid Receptor System at the Interface of Hyperalgesia/Hyperkatifeia and Addiction
Marchette, R. C. N., Vendruscolo, L. F., & Koob, G. F. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00618-x · Cited by 19
“In chronic pain models, there is higher KOR binding in the CeA [96–98].”
Pérez-Fernández, M., Suárez-Rojas, I., Bai, X., Martínez-Martel, I., Ciaffaglione, V., Pittalà, V., Salerno, L., & Pol, O. (2023) · Antioxidants · doi:10.3390/antiox12101794 · Cited by 9
“These data propose the use of 1m, 1a, 1b, and DMF, especially 1m, as new effective treatments for inflammatory pain and related emotional syndromes.”
MethodRasouli, B., Rashvand, M., Mousavi, Z., & Haghparast, A. (2020) · Peptides · doi:10.1016/j.peptides.2020.170401 · Cited by 10
Wang, Y. Y., Li, Y., & Zhou, Z.-F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34870 · Cited by 8
Antioch, I., Ilie, O., Ciobica, A. S., Doroftei, B., & Fornaro, M. (2020) · Medicina · doi:10.3390/medicina56100504 · Cited by 12
Massaly, N., Markovic, T., Creed, M. C., Al‐Hasani, R., Cahill, C. M., & Morón, J. A. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.09.002 · Cited by 15
Metadata
- Authors
- Narita, M., Kaneko, C., Miyoshi, K., Nagumo, Y., Kuzumaki, N., Nakajima, M., Nanjo, K., Matsuzawa, K., Yamazaki, M., & Suzuki, T.
- Affiliations
- Hoshi University (JP)
- University of Toyama (JP)
- Corresponding author
- Narita, Minoru
- Suzuki, Tsutomu
- Venue
- Neuropsychopharmacology
- Published
- 2005-08-10
- Volume
- 31
- Issue
- 4
- Pages
- 739-750
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2019397294
- Cited by
- 289
- References
- 42
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 10 · 2023: 12 · 2022: 11 · 2021: 19 · 2020: 25 · 2019: 17 · 2018: 16 · 2017: 10 · 2016: 11 · 2015: 19 · 2014: 19 · 2013: 12 · 2012: 10
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- chronic pain, anxiety, amygdala, opioid system, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, dynorphin A, neuropathic pain, sciatic nerve ligation, complete Freund's adjuvant, thermal hyperalgesia, GTPgammaS binding, anxiogenic effects
- MeSH terms
- Amygdala, Analgesics, Opioid, Analysis of Variance, Animals, Anxiety, Behavior, Animal, Benzamides, Chronic Disease, Diazepam, Disease Models, Animal, Dose-Response Relationship, Drug, Drug Interactions, Dynorphins, Freund's Adjuvant, Injections, Intraventricular, Male, Mice, Inbred C57BL, Naltrexone, Narcotic Antagonists, Narcotics, Pain, Pain Measurement, Piperazines, Protein Binding, Pyrrolidines, Reaction Time, Sciatica, Somatostatin, Sulfur Isotopes, Time Factors, Tranquilizing Agents, Guanosine 5'-O-(3-Thiotriphosphate), Rats, Sprague-Dawley, Maze Learning, Enkephalin, Ala(2)-MePhe(4)-Gly(5)-, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.